Almac Group is proud of its global reputation for excellence, delivering expertise right across the drug development lifecycle and offering a tailored solution to each client.
Our client relationships are long term and they are underpinned by one simple commitment:
We will be exceptional, always.
Contributed to almost 70% of FDA approved NMEs from 2015/18
Work with all top 25 BioPharma companies
Latest from Almac
Almac Group Launches Tempod® 1000 to Improve Clinical Site Temperature Data Management
2018-19 Figures Show Almac Group’s Turnover Increased by £85M to £634M
Almac Clinical Technologies Introduces SimplifyTM, an Advanced IRT Solution for Faster Clinical Trials Start-up
Almac Brexit Resource Hub
Partnering to advance human healthExplore our locations
Almac Discovery is an independent, research driven drug discovery company dedicated to the development of novel and innovative therapeutics. Our multidisciplinary team of scientists use cutting edge research techniques to develop First in Class preclinical stage assets. Key research themes include protein homeostasis (specifically focused on deubiquitinase enzymes) and next generation protein drug conjugates.Find out more